Baker Bros. Advisors’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $10M | Hold |
|
|||||
|
2017
Q3 | $9.99M | Hold |
|
|||||
|
2017
Q2 | $8.91M | Hold |
|
|||||
|
2017
Q1 | $7.77M | Hold |
|
|||||
|
2016
Q4 | $7.46M | Hold |
|
|||||
|
2016
Q3 | $7.49M | Hold |
|
|||||
|
2016
Q2 | $8.75M | Hold |
|
|||||
|
2016
Q1 | $7.86M | Hold |
|
|||||
|
2015
Q4 | $7.96M | Hold |
|
|||||
|
2015
Q3 | $6.29M | Hold |
|
|||||
|
2015
Q2 | $7.41M | Hold |
|
|||||
|
2015
Q1 | $5.66M | Sell |
|
|||||
|
2014
Q4 | $3.91M | Hold |
|
|||||
|
2014
Q3 | $3.45M | Hold |
|
|||||
|
2014
Q2 | $4.57M | Hold |
|
|||||
|
2014
Q1 | $4.94M | Hold |
|
|||||
|
2013
Q4 | $3.86M | Hold |
|
|||||
|
2013
Q3 | $3.18M | Hold |
|
|||||
|
2013
Q2 | $2.75M | Buy |
|